Recent Finacing
Recent Raise
BigHat Biosciences operates Milliner, an AI/ML-driven design-build-test platform integrating high-throughput synthetic biology, mammalian and cell-free expression to design, synthesize, and characterize hundreds of optimized antibody therapeutics weekly.
